Clinical Trial Update: Surufatinib, Toripalimab and Chemotherapy in Second-line MT and MSS CRC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial updating surufatinib, toripalimab, and chemotherapy in second-line metastatic and microsatellite-stable colorectal cancer is ongoing, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Surufatinib (Surufatinib)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Zhejiang University | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN